Replies to post #134807 on Biotech Values

[DewDiligence]

BAX/Gammagard for AD—If there is no stop [for futility] then they will start enrolling a second (confirmatory) trial.

The second trial is now open for business:

http://finance.yahoo.com/news/Baxter-Initiate-Second-Phase-bw-1469888077.html?x=0

It is identical in every way to the first Gammagard AD trial.

[DewDiligence]

BAX must think its investors have really busy calendars:

http://finance.yahoo.com/news/Baxter-Host-Investor-bw-3297509694.html?x=0

:- )

[DewDiligence]

BAX starts phase-3 stem-cell trial in heart disease:

http://finance.yahoo.com/news/Baxter-Initiates-Phase-III-bw-3094084748.html?x=0

Baxter International Inc. (NYSE:BAX) announced today that it has initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous CD34+ stem cells to increase exercise capacity in patients with chronic myocardial ischemia (CMI).

[DewDiligence]

HyQvia is the brand name for BAX/HALO’s subcutaneous IGIV:

http://finance.yahoo.com/news/baxter-presents-long-term-data-213000121.html

It would be a great Scrabble word if it weren’t a proper noun.